title: [Urolesan in the treatment of stenocardia patients].
abstract: Urolesan was used in the treatment of patients with chronic ischemic heart disease. It was established that urolesan favours improvement of the state of the vascular component of microcirculation, aggregation of erythrocytes, increase of the peripheral circulation, normalization of the blood coagulation system, optimization of external respiration, normalization of the activity of serum aminotransferases. These changes were particularly pronounced in exertion stenocardia.
authors.forename: E M
authors.initials: EM
authors.lastname: Neĭko
authors.forename: Z V
authors.initials: ZV
authors.lastname: Duma
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Del'va
authors.forename: B Iu
authors.initials: BIu
authors.lastname: Shpak
authors.forename: M V
authors.initials: MV
authors.lastname: Debenko
mesh_terms: D000787:Angina Pectoris / Q000188:drug therapy* / Q000503:physiopathology; D002908:Chronic Disease; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology; D004176:Dipyridamole / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D005082:Physical Exertion; D010936:Plant Extracts / Q000627:therapeutic use*
chemical_list: D010936:Plant Extracts; C049031:urolesan; D004176:Dipyridamole
vernacular_title: Urolesan v lechenii bol'nykh stenokardieĭ.